Work

A randomized controlled trial of antibody response to 2019–20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults

Year: 2021

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2021.12.034

Authors: Katherine V. Williams, Bo Zhai, John F. Alcorn, Mary Patricia Nowalk, Min Z. Levine, Sara S. Kim, Brendan Flannery, Krissy Moehling Geffel, Amanda Jaber Merranko, Jennifer P. Nagg, Mark Collins, Michael Susick, Karen S. Clarke, Richard K. Zimmerman, Judith M. Martin

Institutions: University of Pittsburgh, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, UPMC Health System, University of Pittsburgh Medical Center

Language: English

Topic: Influenza Virus Research Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Centers for Disease Control and Prevention, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences

Awards: G4973516974, OUTPATIENT VE FOR SEASONAL FLU, PANDEMIC FLU AND RSV IN A LARGE, DIVERSE NETWORK, G9000015725, University of Pittsburgh Clinical and Translational Science Institute, Institutional Career Development Core, J. NRSA Training Core, Pittsburgh Training Grant in Pediatric Pulmonary Medicine

OpenAlex ID: W4226262500

FWCI: 1.801

Cites: 20

Cited by: 12

Related to: 10